课题基金 / 基金详情

Musculoskeletal functional ability in three diverse Sub-Saharan Africa Populations; assessing muscle strength & function to understand healthy ageing

Musculoskeletal functional ability in three diverse Sub-Saharan Africa Populations; assessing muscle strength & function to understand healthy ageing
撒哈拉以南非洲三种不同人群的肌肉骨骼功能能力;
批准号:
MR/W003961/1
负责人:
Kate Ward
金额:
$104.25万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Around the world people are living longer than ever before. There are now 1 billion people aged over 60 years. In Africa, rising life expectancy is most rapid. The United Nations declaration of the Decade of Health Ageing 2021-2030 states there has never been a timelier opportunity to act to ensure the health of ageing adults, their families and communities. But ageing brings risk of disease, with muscles, bones and joints commonly affected (musculoskeletal disease), which limits walking and daily life. Often diseases exist together, such as with HIV and/or diabetes, this is known as multimorbidity. Multimorbidity is a high priority for global health research. Importantly, one third of all multimorbidity cases across the world include musculoskeletal disease. Currently musculoskeletal diseases account for disability than cancer and heart disease combined. Loss of muscle strength and function is a common manifestation of ageing (known as sarcopenia), which leads to falls and fragility fractures (broken bones from low impact injuries), disability, frailty, and sometimes death. Despite this, little is known about how muscle ages in people living in sub-Saharan Africa (SSA), nor the risk factors for muscle loss or the impact on quality of life. We will study three different populations in The Gambia, Zimbabwe and South Africa. Aiming to:i. How commonly muscle strength is impaired, physical functional is limited and sarcopenia is experienced.ii. Understand to what extent losses in muscle strength and ability reduce the ability to perform activities of daily life, increase the risk of frailty and disability and how these impact quality of life.iii. Identify clinical, nutritional and metabolic risk factors for losses muscle function, to inform approaches to reduce future disability, and promote healthy ageing in SSA. Work package 1: What is the epidemiology of muscle strength, mass and function in each country? We collaborate with a team currently planning extensive community surveys in The Gambia, Zimbabwe and South Africa, which will measure spine fractures in 5040 men and women aged 40 years and over. We have a unique and time-limited opportunity to add to these surveys, data collection and detailed measurements of muscle strength, mass and function, to answer our specific study questions. We will collect data from questionnaires (e.g. joint and back pain, ability to work around the house, quality of life), body composition scans (to quantify fat and muscle mass), X-rays (to quantify osteoarthritis), muscle strength, walking and balance tests (to measure frailty), and blood tests. We will quantify levels of all musculoskeletal multimorbidities including sarcopenia, and determine how these affect disability and quality of life. Work package 2: What are the clinical, nutritional and metabolic risk factors for low muscle strength, mass and function? Identifying risk factors for muscle impairment will aid understanding of the mechanisms underlying muscle dysfunction and highlight biomarkers that can predict disease and disability, with potential use in clinical settings. We will examine clinical (e.g. HIV, diabetes, physical inactivity, osteoarthritis) and nutritional risk factors (e.g. malnutrition, food insecurity, obesity), and measure 184 markers of metabolism and inflammation using the latest proteomic analysis of blood samples, to see which predict age-related losses in muscle.We will feedback our findings to local communities, national health leads and policy makers, and international researchers.This project grant offers a unique and highly-cost effective opportunity, taking advantage of a funded research platform. This MRC investment would permit detailed and novel study of muscle in some of the most rapidly ageing populations in the world. This presents a time-limited opportunity to answer these important research questions focusing on muscle health and functional ability.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/jbmr.4752
发表时间: 2023-03
期刊: JOURNAL OF BONE AND MINERAL RESEARCH
影响因子: 6.2
作者: [Mukwasi-Kahari, Cynthia, Rehman, Andrea M., Breasail, Micheal O., Rukuni, Ruramayi, Madanhire, Tafadzwa, Chipanga, Joseph, Stranix-Chibanda, Lynda, Micklesfield, Lisa K., Ferrand, Rashida A., Ward, Kate A., Gregson, Celia L.]
通讯作者: Gregson, Celia L.
DOI: 10.1002/jcsm.13069
发表时间: 2023-02
期刊: Journal of cachexia, sarcopenia and muscle
影响因子: --
作者: []
通讯作者:
DOI: 10.1038/s41598-022-13548-9
发表时间: 2022-06-09
期刊: Scientific reports
影响因子: 4.6
作者: []
通讯作者:
UKRI MRC National Musculoskeletal Ageing Network: strategic prioritisation to increase healthy lifespan and minimise physical frailty.
UKRI MRC 国家肌肉骨骼衰老网络:战略重点是延长健康寿命并尽量减少身体虚弱。
DOI: 10.1007/s11657-022-01172-z
发表时间: 2022
期刊: Archives of osteoporosis
影响因子: 3
作者: [Harvey NC]
通讯作者: Harvey NC
8
    国内基金
    海外基金
    Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
    • 批准号:
      82371801
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      周海波
    • 依托单位:
    利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
    • 批准号:
      82371145
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      陶永
    • 依托单位:
    SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
    • 批准号:
      82371873
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      乔洁
    • 依托单位:
    基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
    • 批准号:
      82371373
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      沃雁
    • 依托单位: